Suspected acute exacerbation of idiopathic pulmonary fibrosis associated with interferon alpha therapy for hepatitis C: case report

por Ling, Victoria Yee-May, Mortimore, Marianne, Serisier, David J
Publicado 2013

Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum

por Serisier, David J, Carroll, Mary P, Shute, Janis K, Young, Simon A
Publicado 2009

Respiratory microbiota: addressing clinical questions, informing clinical practice

por Rogers, Geraint B, Shaw, Dominick, Marsh, Robyn L, Carroll, Mary P, Serisier, David J, Bruce, Kenneth D
Publicado 2015

Republished: Respiratory microbiota: addressing clinical questions, informing clinical practice

por Rogers, Geraint B, Shaw, Dominick, Marsh, Robyn L, Carroll, Mary P, Serisier, David J, Bruce, Kenneth D
Publicado 2015

Bacterial activity in cystic fibrosis lung infections

por Rogers, Geraint B, Carroll, Mary P, Serisier, David J, Hockey, Peter M, Kehagia, Valia, Jones, Graeme R, Bruce, Kenneth D
Publicado 2005

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial

por Serisier, David J, Bilton, Diana, De Soyza, Anthony, Thompson, Philip J, Kolbe, John, Greville, Hugh W, Cipolla, David, Bruinenberg, Paul, Gonda, Igor
Publicado 2013

Adult Non-Cystic Fibrosis Bronchiectasis Is Characterised by Airway Luminal Th17 Pathway Activation

por Chen, Alice C.-H., Martin, Megan L., Lourie, Rohan, Rogers, Geraint B., Burr, Lucy D., Hasnain, Sumaira Z., Bowler, Simon D., McGuckin, Michael A., Serisier, David J.
Publicado 2015